Effect of free trade agreements on pharmaceutical market competition: The case of the 2009 US-Peru free trade agreement and its implementation as national drug policy

by Lita Araujo, Enrique Seoane-Vazquez, Michael Montagne
Published 2021-12-01

Innovation and competition in advanced therapy medicinal products

by Enrique Seoane‐Vazquez, Vaishali Shukla, Rosa Rodriguez‐Monguio
Published 2019-03-01

Predictors of shortages of opioid analgesics in the US: Are the characteristics of the drug company the missing puzzle piece?

by Rosa Rodriguez-Monguio, Mahim Naveed, Enrique Seoane-Vazquez
Published 2021-01-01

Changes in the utilization of osteoporosis drugs after the 2010 FDA bisphosphonate drug safety communication

by Bander Balkhi, Enrique Seoane-Vazquez, Rosa Rodriguez-Monguio
Published 2018-02-01

Cost-effectiveness analysis of metformin+dipeptidyl peptidase-4 inhibitors compared to metformin+sulfonylureas for treatment of type 2 diabetes

by Christina S. Kwon, Enrique Seoane-Vazquez, Rosa Rodriguez-Monguio
Published 2018-02-01

Fixed-Dose Combination Drug Approvals, Patents and Market Exclusivities Compared to Single Active Ingredient Pharmaceuticals.

by Jing Hao, Rosa Rodriguez-Monguio, Enrique Seoane-Vazquez
Published 2015-01-01

Impact of an Advanced Practice Pharmacist Type 2 Diabetes Management Program: A Pilot Study

by Jelena Lewis, Tiffany Nguyen, Hana Althobaiti, Mona Alsheikh, Brad Borsari, Suzanne Cooper, David Kim, Enrique Seoane-Vazquez
Published 2019-12-01